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In 1980, Donabedian defined high quality care
as “that kind of care which is expected to maximise
an inclusive measure of patient welfare, after one
has taken account of the balance of expected gains
and losses that attend the process of care in all its
parts” [4]. One of the most widely cited recent def-
Quality of health care has been a subject of at-
tention for many years in the USA and in Europe.
Since the introduction of the new federal law on
insurance in 1996 it has evolved to a progressively
more important issue within the Swiss health care
system. In this review, some theoretical concepts
of quality of health care, variations, and surveil-
lance systems are explored. Examples of quality of
health care surveillance systems that have been
developed successfully in the USA, in Canada, in
Australia, and in Europe are discussed. They all
demonstrate the interest in creating a large range
of quality indicators in the surveillance system and
in evaluating hospital performance using a bench-
mark approach. Currently, the measurement of
quality with appropriate indicators is a subject of
intense debate between the Swiss Hospitals Asso-
ciation (H+) and the Swiss Health Insurance Con-
sortium (Santésuisse). Examples of existing sur-
veillance systems in Switzerland are the Outcome
Verein in Zurich and the quality of care program
of the Canton of Valais. The FoQual association
has also contributed to the debate by reviewing six
indicators, which could be used nationally for a
healthcare surveillance system. In this debate it is
important to stress that ideal quality indicators
intended for use as measures of quality in Swiss
hospitals need to be both appropriate and valid.
Only indicators that fulfil these conditions should
be integrated in a Swiss health care surveillance
system. Priority needs to be given to quality indi-
cators and methods with the highest level of
evidence and with a solid scientific basis. 
Introduction
Since more than 20 years, quality has been a
topic of interest in health care, which has increased
for several reasons. The most important factor is the
variation in care outcomes that cannot be explained
by differences in patient characteristics, first de-
scribed in detail by Wennberg and colleagues [1]. A
second reason is the growth of costs and the rising
utilisation of health care services. These concerns
have spurred interest in quality and quality im-
provement as a means of controlling growth and
improving service. 
In this review we will first address some basic
concepts in quality of health care, including defi-
nitions and measurement. We will describe how
and why variations in care can occur, and go on to
describe the tools used to measure quality of health
care, including surveillance systems. Several mod-
els (and activities), both international and Swiss,
will be presented. Finally, we will discuss the im-
plementation of surveillance systems in the Swiss
setting with examples from the Outcome Verein in
Zürich [2], the indicators reviewed by the FoQual
association [3], and the more detailed description
of the current quality of care program of the canton
of Valais. These Swiss examples are presented in the
light of the intense debate currently taking place
between the Swiss Hospitals Association (H+) and
the Swiss Health Insurance Consortium (Santé-
suisse) on which quality indicators are appropriate
for use in the measurement of hospital performance.
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Quality of health care 
initions, formulated by the Institute of Medicine
in 1990, holds that quality consists of the “degree
to which health services for individuals and popu-
lations increase the likelihood of desired health
outcomes and are consistent with current profes-
sional knowledge” [5].
Measuring quality of care has traditionally re-
lied on the structure-process-outcome framework
developed by Donabedian [4]. Structural factors
are the characteristics of health care professionals
and hospitals. They include the tools and resources
available to providers as well as their physical and
organisational setting. Structure embraces the
human, physical and financial resources that are
needed to provide medical care. For Donabedian
good structure includes, for example, sufficient re-
sources and proper system design as key points to
ensure good quality of care. Process data are the
components of the encounter between a physician
or other health care professional and a patient (e.g.
tests, medications ordered or information shared
with the patient). Acceptable or good processes are
the characteristics of use of services relative to
need, for example, appropriateness of diagnostic
procedures and treatments or adherence to pro-
fessionally defined norms of good practice, such as
evidence-based clinical guidelines. Processes also
include the way providers deal with patients in
terms of concern, courtesy, respect and time spent
with the patient. Outcome refers to the change in
the patient’s current and future health status that
can be attributed to antecedent health care. Typi-
cal examples of outcome data are in-hospital mor-
tality rate, readmission rate, functional status,
quality of life, patient satisfaction and costs. In
defining these terms Donabedian made the dis-
tinction between client-related outcomes and
practitioner-related outcomes. He argued that
provider satisfaction in addition to patient satis-
faction is an important measure of system effec-
tiveness. 
The traditional structure-process-outcome
model described by Donabedian in order to
demonstrate how to measure the quality of care
with indicators as well as quality of care services
system is only one part of the quality improvement
circles. These circles are often defined in terms of
Plan, Do, Check, Act cycles. The Check part is re-
lated to quality indicators and the Act part to the
continuous quality improvement initiatives. These
are structured organisational improvement initia-
tives within healthcare systems aimed at providing
better care that meets customer expectations.
From these quality circles, models have also been
developed, such as total quality management
(TQM) and European foundation for quality man-
agement (EFQM). 
Health surveillance systems need to be con-
ducted using valid and reliable quality indicators.
Good indicators should be linked to and predict
directly the quality of health care, as for example
nosocomial infections. On the other hand read-
missions for complications are poor indicators, be-
cause they are only indirectly related to the qual-
ity of care. To be valid indicators they need to
measure what they were intended to measure. Fi-
nally, indicators should also be reliable. Repeated
measurements of a stable phenomenon, by differ-
ent people and instruments, at different times and
places, should yield similar results.
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Variations in care
Over the past few decades the importance of
the variation phenomenon in modern medicine
has been shown. In particular, differences are ob-
served in the way apparently similar patients are
treated in one hospital compared to another [6].
John Wennberg is a pioneer in this field and his
findings on small area variations represent very im-
portant steps in health services research. In a fa-
mous paper he was the first to demonstrate the
large variation in resource input, utilisation of
services, and expenditure between two similar
communities in Vermont [7]. He went on to
demonstrate large variations of hospital use and
expenditure for inpatient use between Medicare
beneficiaries in two US towns (Boston and New
Haven). These findings had an impact on the at-
tention given to outcome and the cost implications
of differences in practice styles [1]. In a further
study comparing the same areas he showed that
patients in Boston have higher rates of discharge,
readmission, length of stay, and reimbursement
compared to patients in New Haven [8].
Different explanations exist for these varia-
tions. Some have argued that each physician has an
individually unique knowledge on how to diagnose
and treat patients. Another explanation might be
that variations in health care are due to the avail-
ability of supply in health care resources [9]. An-
other argument is related to practice volume [10].
Some authors argue for the “enthusiasm hypothe-
sis”. This reflects the idea that key personalities lo-
cally influence physicians in an area on how to treat
patients [11]. Another argument stresses that vari-
ations in the use of health services were due to
inappropriate care [12]. Variations in health care
management and delivery have also been demon-
strated previously in cardiology in the use of car-
diac procedures after acute myocardial infarction
[13–17], in the use of coronary artery bypass sur-
gery [18–21], and in the treatment of patients with
congestive heart failure [22, 23]. 
Outcome Variations
Outcome is defined by Donabedian as “a change
in the patient’s current and future health status that
can be attributed to antecedent health care” [4].
The outcome movement has flourished in the US 
in the last two decades with an enormous growth of
activities such as the assessment of outcomes, the
analysis of effectiveness and quality assurance [24].
Many factors have promoted and triggered this
movement in the US. One factor is the increase of
health care costs and the need for cost containment.
In this situation outcome measures are necessary to
detect deterioration in quality. Other factors are in-
creased competition and the answers needed to ex-
plain John Wennberg’s research findings on small
area variations [1, 7, 8]. In particular, differences in
the hospital-to-hospital management of patients
with different diseases have been described. The
persistence of differences in outcomes after control-
ling for case-mix factors leads to the argument that
other factors such as process of care or structural fac-
tors must influence outcomes.
Variations in outcomes have been demonstrated
in many studies, especially in the US. In particular
hospital mortality has been shown to vary across
hospitals [25, 26]. Other studies found that variations
in hospital mortality for surgical patients were due
to the volume of these specific surgical procedures
performed in the hospital [27, 28]. The interpreta-
tion of the results of these and many similar studies
is controversial. One group argued that meaningful
comparison of hospital death rates requires adjust-
ment for severity of illness [29]. This group also in-
sisted that new methods need to be found to target
lower quality hospitals when using mortality as a
quality indicator. These new methods need to en-
sure that high death rates are not due to random
variations. Secondly, the quality of care in selected
hospitals should also be compared using medical
records data. Thirdly, comparison should include
both implicit (outcomes) and explicit (structure and
process measures) assessment of the quality of care.
Fourthly, the evaluation should be public and ac-
cepted by professionals. Finally, detailed data on
severity of illness and comorbidity should be col-
lected to ensure a proper case-mix control [30]. 
S W I S S  M E D  W K LY 2 0 0 2 ; 1 3 2 : 4 6 1 – 4 6 9 ·  w w w. s m w. c h 463
Indicators quality of healthcare program, Canton of Valais, Switzerland
surveillance of the quality indicators quality improvement initiatives*
already proposed automatic already proposed 
existing for the next extraction to the existing for the next 
5 years data-warehouse 5 years 
1. Structure indicators
Number of stays, operating rooms, or other + + + + + 
indicators derived from administrative data
2. Process indicators
Evaluation of the quality of coding + + – + +  
Use of broad spectrum antibiotics + + + + +  
Vaccination coverage of the staff, + + – + +  
for hepatitis B and influenza 
Surveillance of drug prescription + + + + +
Audit of the anaesthesiology ward – + + – +
Treatment and management of congestive – + + – +
heart failure
Treatment and management of acute – + + – +
myocardial infarction
Treatment and management of community – + + – +
acquired pneumonia
Nursing data + + + + +
3. Outcome indicators
Routine indicators from administrative data, + + + – +
such as mortality in-hospital, 
unplanned readmissions, length of stay
Review of hospitalisations + + – – –
Chart review for unplanned readmissions + + – + +
Surgical site infections + + – + +
Prevalence of nosocomial infections + + – + +
Surveillance of bacteraemia + + – + +
Patient satisfaction + + – + +
Staff satisfaction – + – – +
Patient security (incident register) – + – – +
* These include feedback, dissemination of evidence-based clinical guidelines, use of reminders, or opinion leaders
Table 1
Quality of Health
Care Surveillance in
the Canton of Valais:
existing data and
action plan for the
next five years.
Public health surveillance is the ongoing sys-
tematic collection, analysis and interpretation of
health data, closely integrated with the rapid dis-
semination of health data both to those providing
the data and to those who can apply the data to con-
trol and prevention programs [31]. Appreciation is
growing that public health surveillance systems
can be adapted for use in programs to improve the
quality of care delivered to patients. This depends
on the active participation of individual clinicians
and hospitals in the assessment and improvement
of the quality of medical care. 
Examples of hospital-wide surveillance acti-
vities include quality assurance programs conducted
in the US by the Joint Commission on the Ac-
creditation of Healthcare Organizations (JCAHO)
and Medicare. JCAHO developed standards on
how to monitor and evaluate processes and on how
to implement a surveillance system for processes
in a hospital. 
Monitoring and evaluation must be under-
taken hospital-wide, including both medical staff
functions and hospital service functions. Areas that
might benefit from monitoring and evaluation
include each medical staff department or clinical
service, surgical procedure case review, drug and
blood products usage, pharmacy and therapeutics
function, infection control and safety. In each or-
ganisational unit, the staff must consider the care
they provide and the procedures they perform and
identify the most important aspects of that care,
which because of higher risk, or the greater vol-
ume, are the most prone to problems. Considera-
tion should be given to the appropriateness of care
and if that care is performed properly [32].
In the US, more than 10 years ago the Health-
care and Financing Administration (HCFA) start-
ed to implement a programme to measure and
track the quality of care for Medicare beneficiaries
[33]. HCFA implemented surveillance systems in-
cluding 24 initial measures, which include quality
indicators for heart failure, acute myocardial in-
farction, pneumonia, stroke, breast cancer and
diabetes. Performance on these quality indicators
has been reported state wise [34]. A similar ap-
proach is now used by the Joint Commission 
on Accreditation of Healthcare Organisations
(JCAHO), who launched the ORYX initiative to
establish a continuous, data-driven accreditation
process through the incorporation of performance
measurement data. These initiatives allow a con-
tinuous, data-driven accreditation process for hos-
pitals, providing then an additional tool to be used
in their internal quality improvement efforts and
allowing comparative evaluations between hospi-
tals. These surveillance systems include perform-
ance measures for heart failure, acute myocardial
infarction, pneumonia, some surgical procedures
and complications, and some pregnancy related
conditions. The ORYX score measures for acute
myocardial infarction, heart failure and pneumo-
nia are derived from the HCFA quality indicators
[35].
Other examples of quality of care surveillance
systems have been developed in countries outside
the US. For example in Ontario, Canada, quality
indicators have been developed to compare hospi-
tals regarding quality of care for the following ten
conditions: acute myocardial infarction, heart fail-
ure, stroke, pneumonia, asthma, gastrointestinal
haemorrhage, cholecystectomy, hysterectomy,
prostatectomy, and carpal tunnel release surgery
[36]. For these conditions, selected outcomes, such
as complications, length of stay, readmission and
access to technology are measured. With this sur-
veillance system one can monitor quality of care in
each hospital in the province of Ontario. The Aus-
tralian Council on Health Care standards has also
developed a similar surveillance system using clin-
ical indicators to monitor the quality of hospital
care. Australia has also been a leader in developing
quality indicators for health care organisations. In
1999, 191 quality indicators were used for almost
all medical specialities. The goal of this surveil-
lance system was to demonstrate to hospitals how
they compared to other health care organisations
and if they had a potential to improve the quality
of health care. Before benchmarking between in-
stitutions several limitations need to be taken into
account including controlling for case-mix, for the
size and for the goal of the hospital (teaching, non
teaching). In these systems the Australian Council
on Healthcare Standards has divided their quality
indicators by medical categories such as adverse
drug reactions, anaesthetics, day procedures, in-
tensive care, emergency medicine, internal medi-
cine, psychiatry, etc. One indicator use in the
emergency medicine branch is for example,
“thrombolysis initiated within 1 hour of presenta-
tion for acute myocardial infarction” [37]. In the
UK, the National Health Service has developed a
performance-rating system which includes struc-
ture and process measures covering many aspects
of hospital activities, such as waiting list, waiting
time, operation cancelled, hospital cleanliness, sat-
isfactory financial position, etc. Several perform-
ance measures are also used with clinical, staff and
patient oriented indicators. Clinical focused mea-
sures include death in hospital within 30 days of
surgery, emergency readmission rates and clinical
negligence. Patient focused indicators are related
to waiting time and staff focused on qualification
and absence rates [38]. Similar approaches using a
surveillance system with quality indictor measures
have also been used in France, where performance
measure have been developed in many clinical
areas [39, 40].
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Surveillance systems and quality assurance
In the United States more than 4 million peo-
ple currently suffer from congestive heart failure
(CHF) (1.6% of the general population), and ap-
proximately 400000 new cases are diagnosed each
year. Mortality is high with 6-year mortality rates
of 80% in men and 65% in women [41]. As the
population ages the crude incidence of heart fail-
ure and its mortality rate will continue to increase.
According to the Health Care Finance Organiza-
tion (HCFA), the in-hospital mortality rate for
Medicare patients with CHF was 7% in 1992. In
two older studies, the 30-day mortality rates were
about 15% for CHF among Medicare patients 
[42, 43]. In the United Kingdom the prevalence of
CHF among the general population is estimated
to be between 0.4% and 1.5% and 5% of all adult
hospital admissions are due to heart failure [44]. In
Switzerland about 210000 people have CHF, of
which 68% are treated and 47% have received an-
giotensin-converting enzyme inhibitors (ACEI)
[45].
Measurement of Process Indicators 
In the United States, both the Agency for
Health Care Policy and Research (AHCPR) and
the American College of Cardiology (ACC) have
published guidelines related to the diagnosis and
management of patients with congestive heart fail-
ure [46]. Recently, the Advisory Council To Im-
prove Outcomes Nationwide in Heart Failure
(ACTION HF) has also published an update of
these guidelines [47]. In Europe, similar evidence-
based clinical guidelines have also been published
[48]. 
Congestive heart failure exemplifies a disease
with high morbidity, mortality and high cost. Most
of the time CHF occurs in elderly patients, who
have high readmission and mortality rate. In addi-
tion internationally recognised evidence-based
guidelines exist for the management and treatment
of patients with CHF. In particular, all patients
hospitalised with CHF, not previously investi-
gated, should undergo an investigation to assess
their ejection fraction and to determine if their
ventricular dysfunction is predominantly systolic
or diastolic. All patients with left ventricular sys-
tolic dysfunction should receive angiotensin con-
verting enzyme inhibitors at target dose. 
Poor process has negative impacts on health
outcomes. Kahn et al. showed that patients hospi-
talised with CHF, who received poor quality care,
defined by explicit process criteria had increased
30 days post hospital discharge death rates [49]. A
study conducted in five US states with Medicare
beneficiaries admitted with a diagnosis of CHF as
part of the Health Care Quality Improvement
Program from the Health Care and Financing Ad-
ministration (HCFA). The results showed that pa-
tients who received target dose ACEI had a better
survival compared to patients who had less than
target dose ACEI or no ACEI [50]. 
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Quality of care for congestive heart failure (CHF), 
an example of a surveillance scheme
Quality of care initiatives in Switzerland
Whereas in the USA quality of care research
and clinical evaluation have been steadily develop-
ing over the past 20 years, there was no large in-
terest in Switzerland until recently. Increasing
health care costs have stimulated the demand for a
more systematic evaluation of the health care sys-
tem and allowed research on quality of care to be
developed. The new federal law on universal med-
ical insurance requires that “scientific and system-
atic measures to guarantee the quality and the ap-
propriateness of care …” should be implemented.
A survey conducted in 1994 among clinical de-
partment heads at Swiss university hospitals in-
quiring about quality assurance activities indicated
that assessment of quality could be improved. For
example, only 67% of the respondents knew the
department mortality rate and only 33% knew the
department adverse treatment effects rate [51]. 
Quality of care initiatives have been progres-
sively developed in many clinical care settings. In
addition, modern development in quality of care
monitoring and improvement in industry and serv-
ices (including public services) has been associated
with the growing offer of various training pro-
grammes in quality. Some collaborators of health
care institutions have made use of such opportuni-
ties. Moreover, multiple short courses and semi-
nars have been offered to executives, managers and
staff of health care services. Large hospitals as well
as smaller entities have created positions for qual-
ity specialists. Consultants and associations, with
various degrees of skills, resources and know-how,
have offered their services to hospitals and health
care institutions. Accreditation, certification [52]
and total quality management programs have been
started.
The Swiss Medical Association is working on
developing or implementing various projects to
ensure or improve quality of care. A task force is
currently elaborating a policy for the formulation
of multidisciplinary national guidelines to be de-
veloped jointly with the specialty societies involved
in a specific medical condition. Various options
have been used to measure quality of care. 
Health service research is also an area of in-
terest in Switzerland. In particular several studies
have been implemented to assess the appropriate-
ness of medical care [53]. One study examined the
appropriateness of indications for surgery of lum-
bar disc hernia and spinal stenosis in patients un-
dergoing surgery in two university hospitals. The
criteria used to assess appropriateness of indica-
tions were formulated using the method developed
by the Rand Corporation [54]. In that study the
criteria, established by an American panel, identi-
fied a large percentage (38%) of inappropriate pro-
cedures [55]. Another study tested the appropri-
ateness of referrals for upper gastrointestinal en-
doscopy in an open access endoscopy unit using
the criteria of the American Society for Gastroin-
testinal Endoscopy, here only 57% of the indica-
tions were judged appropriate [56]. A larger study
was then conducted using explicit Swiss criteria de-
veloped by the RAND-UCLA panel method. The
results showed that 49% of these procedures were
inappropriate and that overuse of upper gastroin-
testinal endoscopy occurred in 5.1% of patients
who presented with upper gastrointestinal symp-
toms [57]. The same set of patients was also used
to assess under-use of upper gastrointestinal en-
doscopy, which was shown to be substantial [58].
In the same context of gastrointestinal endoscopy,
the agreement between American and Swiss ap-
propriateness criteria was shown to be large [59,
60]. Besides the research projects, the group has
tried to disseminate appropriateness methods and
quality assurance concepts in the local medical
community [61–63].
Few studies on small area variations in health
care utilisation have been conducted in Switzer-
land. One study found large geographical varia-
tions in coronary arteriography rates in Switzer-
land [64]. Another study looked at regional varia-
tions in the rate of operations for hip fractures in
the Canton of Vaud [65].
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Existing quality of health care surveillance initiative in Switzerland
As in the US, quality of care in Switzerland is
not optimal in many health care settings, in par-
ticular for the management and treatment of pa-
tients with congestive heart failure. As in the US,
variations in treatment of patients with CHF by
physicians and institutions exist. To reduce varia-
tions, evidence-based clinical practice guidelines
have been developed in the US, and to a less ex-
tent in Switzerland. HCFA has developed a sur-
veillance system for CHF patients using valid and
reliable quality indicators derived from evidence-
based guidelines. This strategy will also be devel-
oped in Switzerland in the near future. Currently
the Swiss Hospitals association is debating with the
Swiss Health Insurance Consortium on what type
of quality indicators should be used in Switzerland
to monitor hospitals. In this debate, it is important
to stress that only appropriate and valid indicators
should be used for healthcare surveillance systems.
It is not easy to know which indicators are best
suited for general use in a Swiss setting. The
framework developed by the association FoQual
aimed at answering this question. For six indica-
tors they described in detail: representativeness,
possibilities for general use, validity and reliability
of the performance measure, case-mix, inter-
pretability, application, research and development,
costs and recommendations. Each of these ques-
tions needs to be asked for each and every indica-
tor that might be developed and employed [3].
A few quality of health care surveillance sys-
tems have already been developed in Switzerland.
In particular, in 1995 the Ministry of Health of the
canton of Zürich started a performance-oriented
resource allocation project. Several instruments
for the measurement of outcomes in acute hospi-
tals were defined and tested. This project resulted
in the development of 10 tracer diagnoses and 12
global indicators, which are now used on a manda-
tory base in all the hospitals in the canton of Zürich
[66, 67]. The indicators developed by this project
include waiting time, delays and postponement of
interventions, as well as patient satisfaction mea-
sures. For each tracer diagnosis, several quality
indicators have been developed. The main tracer
diagnoses include appendicitis, acute myocardial
infarction, stroke, birth and prostatic hyperplasia
[2]. Similar developments will soon take place in
several other Swiss cantons.
The association FoQual was recently created
in the French and Italian speaking parts of the
country and includes researcher and quality spe-
cialists from several cantons. In a first step, using
a rigorous scientific approach this group described
six quality indicators including: quality of coding,
patient satisfaction, nosocomial infections, pres-
sure ulcer, readmissions, and treatment for acute
myocardial infarction. The FoQual association
currently recommend introducing four measures
(quality of coding, patient satisfaction, nosocomial
infections and pressure ulcer) as sufficient evi-
dence exists on these quality of care measures.
However the same group stress the importance of
not using crude readmissions to compare hospitals,
even when controlling for the case-mix. Further
research needs to be done on these indicators, es-
pecially on how to ascertain planned readmissions.
The association also recommend that measures to
evaluate the management and treatment of acute
myocardial infarction should not be introduced
until better control for all potential diseases is
achieved. This group is planning to publish new
recommendations in the future, including further
indicators for monitoring medical errors and re-
lated to the use of hospital administrative data such
as mortality and readmissions [3]. The purpose of
the FoQual association was not primarily to de-
velop a surveillance system, but to give recom-
mendations on possible quality indicators in the
Swiss healthcare debate, especially on which indi-
cators are appropriate and valid.
Besides this national effort, a surveillance sys-
tem, which includes quality indicators to monitor
hospitals will be developed in the near future by
the “Réseau Santé Valais” in collaboration with the
Health Observatory in the canton of Valais. The
first step of this surveillance system will be the de-
velopment of quality indicators that allow evalua-
tion and monitoring of different aspects of quality
of care in hospitals. A further step will consist of
quality improvement initiatives, such as feedback,
development and dissemination of evidence-based
clinical guidelines, use of reminders, or opinion
leaders. This initiative constitutes a pilot project.
In the next two or three years, electronic med-
ical records will be installed in each hospital in the
canton of Valais, allowing predefined data to be au-
tomatically extracted to a centralised data ware-
house. By using this system, it will be possible to
collect data for epidemiological research, surveil-
lance, and for quality of healthcare monitoring.
This will eliminate the need for manual extraction
for research projects [68]. 
Table 1 summarises those quality indicators,
which already exist, and those, which will be used
for quality of healthcare surveillance in the canton
of Valais during the next five years. These quality
indicators are categorised into structure, process
and outcome indicators. Structure indicators are
primarily gathered through administrative data, such
as the number of beds, counts of hospital stays, or the
number of operating rooms. Several process indica-
tors have already been collected through the Hospital
Epidemiology Unit of the Central Institute of the
Valais Hospitals (CIVH), such as the use of broad-
spectrum antibiotics [69] and vaccination coverage of
the staff for hepatitis B and influenza. The quality of
diagnostic and intervention codes from administra-
tive data (ICD-10 codes) has been evaluated in 1998
[70]. A new study will assess the accuracy of these
codes for the 2000 data. It is planned to repeat this
evaluation of quality of coding every other year.
Other process indicators will be introduced in
the canton of Valais for surveillance of the quality
of healthcare. These process indicators are related
to the treatment and management of congestive
heart failure, acute myocardial infarction, and
community acquired pneumonia. These diseases
were chosen because of their high mortality, high
morbidity and high costs, and also because clinical
practice guidelines exist for the management and
treatment of these conditions [41, 46, 47, 71–74].
Guidelines are known to have a positive effect on
quality. Although changing physician’s behaviour
is not an easy task, successful implementation of
guidelines has been demonstrated in the Swiss
setting [75]. 
Several outcome indicators will be directly
collected from administrative data, such as in-hos-
pital mortality, readmission, length of stay and
complications. Besides these indicators, several
outcome indicators such as surgical site infections
[76], prevalence of nosocomial infections [77], sur-
veillance of bacteraemia and chart review for un-
planned readmissions have already been collected
through the Hospital Epidemiology Unit of the
CIVH. This will be repeated in the future. Other
outcome indicators will be added to the surveil-
lance system, such as patient satisfaction, staff sat-
isfaction and patient security. 
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Conclusions
Quality of care has been shown to be not al-
ways optimal in many settings, including the Swiss
healthcare system. Precipitated by the introduc-
tion of a new law on medical insurance, a debate
has emerged between the Swiss Hospital Associa-
tion (H+) and the Swiss Health Insurance Con-
sortium (Santésuisse) on the choice of quality in-
dicators to monitor Swiss hospitals. It is important
to choose appropriate indicators. These indicators
need to be valid and reliable, but also readily ap-
plicable and available for general use. In particular
they need to integrate a method to control for case-
mix. These quality indicators are only one part of
a quality improvement circle. Other parts concen-
trate largely on quality improvement initiatives
and are therefore also important in improving 
the quality of the healthcare system. These parts
include quality improvement approaches, evidence-
base clinical guidelines and methods to change
physician’s behaviour.
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